Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8423278 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL8421983 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL22157373 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL28760238 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL11233672 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL6159782 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL28485740 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL8850444 | 0.98 | TSHR (0.46) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL22157363 | 0.98 | TSHR (0.46) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL4140633 | 0.98 | TSHR (0.44) | TSHRDNM1ALDH1A1KCNH2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2516474-B9 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2015-04-08 | — | — | EP | disclosed |
| EP-2516474-B9 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2015-04-08 | — | — | EP | disclosed |
| US-8921502-B2 | Modified polymer compositions | STYRON EUROPE GMBH (CH) | 2014-12-30 | — | — | US | disclosed |
| US-8921502-B2 | Modified polymer compositions | STYRON EUROPE GMBH (CH) | 2014-12-30 | — | — | US | disclosed |
| US-8895684-B2 | Modified polymer compositions | STYRON EUROPE GMBH (CH) | 2014-11-25 | — | — | US | disclosed |
| US-8895684-B2 | Modified polymer compositions | STYRON EUROPE GMBH (CH) | 2014-11-25 | — | — | US | disclosed |
| US-8895684-B2 | Modified polymer compositions | STYRON EUROPE GMBH (CH) | 2014-11-25 | — | — | US | disclosed |
| EP-2516478-B1 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2014-06-11 | — | — | EP | disclosed |
| EP-2516478-B1 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2014-06-11 | — | — | EP | disclosed |
| EP-2516474-B1 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2013-11-06 | — | — | EP | disclosed |
| WO-2011079922-A1 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2011-07-07 | — | — | WO | disclosed |
| WO-2011079922-A1 | MODIFIED POLYMER COMPOSITIONS | STYRON EUROPE GMBH (CH) | 2011-07-07 | — | — | WO | disclosed |
| US-20090035696-A1 | PHOTORESIST COMPOSITION | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20030138846-A1 | Solid phase supports | AKZO NOBEL N.V. (NL) | 2003-07-24 | — | — | US | disclosed |
| US-6486354-B1 | Solid phase supports | AKZO NOBEL N.V. (NL) | 2002-11-26 | — | — | US | disclosed |
| EP-0454622-B1 | Alkenyl substituted stabilizers | CIBA GEIGY AG (CH) | 1999-10-13 | — | — | EP | disclosed |
| US-5268114-A | Oxidation, heat and radiation resistance; for lubricating oil | CIBA-GEIGY CORPORATION (US) | 1993-12-07 | — | — | US | disclosed |
| US-5162408-A | Polypropylene | CIBA-GEIGY CORPORATION (US) | 1992-11-10 | — | — | US | disclosed |
| US-5081300-A | N-alkenyl substituted amine-N-oxide stabilizers | CIBA-GEIGY CORPORATION (US) | 1992-01-14 | — | — | US | disclosed |
| EP-0454622-A1 | Alkenyl substituted stabilizers | CIBA-GEIGY AG (CH) | 1991-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138846-A1 | Solid phase supports | NES, CCNY, CCNA2 | TSHR 4277/4885DNM1 3962/4885ALDH1A1 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.